Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Dry Eye Syndromes

Interventions

DRUG

A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE®

Eyedrops as required, but at least 3 times per day

DRUG

Sodium hyaluronate

Eyedrops as required, but at least 3 times per day

Trial Locations (1)

London